Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic |
📓
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids in health and disease (Lipids Health Dis ) Vol: 20 Issue 1 Pages: 22 Pub: 2021 Feb 26 Epub: 2021 Feb 26 Authors Li F , Ye J , Shao C , Zhong B , Html Article Publication |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic |
📓
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nature communications (Nat Commun ) Vol: 11 Issue 1 Pages: 4982 Pub: 2020 Oct 5 Epub: 2020 Oct 5 Authors Lee G , You HJ , Bajaj JS , Joo SK , Yu J , Park S , Kang H , Park JH , Kim JH , Lee DH , Lee S , Kim W , Ko G , Html Article Publication |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic |
📓
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 9385 Pub: 2020 Jun 10 Epub: 2020 Jun 10 Authors Lang S , Farowski F , Martin A , Wisplinghoff H , Vehreschild MJGT , Krawczyk M , Nowag A , Kretzschmar A , Scholz C , Kasper P , Roderburg C , Lammert F , Goeser T , Steffen HM , Demir M , Html Article Publication |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic |
📓
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD. Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 2771 Pub: 2020 Feb 17 Epub: 2020 Feb 17 Authors Dong TS , Katzka W , Lagishetty V , Luu K , Hauer M , Pisegna J , Jacobs JP , Html Article Publication |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic |
📓
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nature communications (Nat Commun ) Vol: 10 Issue 1 Pages: 1406 Pub: 2019 Mar 29 Epub: 2019 Mar 29 Authors Caussy C , Tripathi A , Humphrey G , Bassirian S , Singh S , Faulkner C , Bettencourt R , Rizo E , Richards L , Xu ZZ , Downes MR , Evans RM , Brenner DA , Sirlin CB , Knight R , Loomba R , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
